Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from milehighcompounds.is, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
Lab "ILS Labs" reports purity within 0.41% std dev across 306 COAs
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 1 | 99.94% |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| MHC-3 RT | GLP-310-MH-03 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| SLU-PP-332 | SLU-PP-MH-02 | Vanguard Laboratory | — | HM | — | View |
| Sermorelin |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| AHK-Cu | 1 | 99.98% | — | — | — |
| AOD-9604 | 1 | 99.96% | — |
| ARA290 | 1 | 99.60% | — | — |
| BPC-157 | 4 | 99.47% | — | — |
| BPC-157/TB-500 | 2 | 99.78% | — |
| Cagrilintide | 1 | 99.95% | — |
| Cardiogen | 1 | 98.38% | — | — |
| Cartalax | 1 | 99.91% | — | — |
| CJC-1295 (No DAC)/Ipamorelin | 1 | 99.87% | — |
| CJC-1295 DAC | 1 | 98.50% | — | — |
| GHK-Cu | 2 | 99.80% | — | — |
| Glow | 1 | 99.74% | — | — |
| GLP-2 TRZ | 2 | 99.81% | — |
| GLP-3 RT | 2 | 99.35% | — | — | — |
| Glutathion | 1 | 99.91% | — |
| IGF-1 LR3 | 1 | 98.87% | — | — | — | — |
| Klow | 1 | 99.69% | — | — |
| KPV | 2 | 99.75% | — | — | — |
| LL-37 | 1 | 99.65% | — | — | — |
| Melanotan-1 | 1 | 99.98% | — | — |
| Melanotan-2 | 1 | 99.97% | — | — |
| MHC-3 RT | 2 | 99.80% | — | — | — |
| MHC-3RT | 2 | 99.80% | — | — | — |
| MOTS-c | 2 | 99.77% | — |
| NAD+ | 3 | 94.94% | — | — |
| Oxytocin | 1 | 99.93% | — |
| Pinealon | 1 | 99.00% | — | — |
| Prostamax | 1 | 98.69% | — | — |
| PT-141 | 1 | 99.93% | — | — |
| Selank | 2 | 99.83% | — | — |
| Semaglutide | 1 | 99.59% | — | — | — | — |
| Semax | 1 | 99.50% | — | — | — |
| Semax/Selank | 1 | 99.80% | — | — | — |
| Sermorelin | 1 | — | — | — | — |
| SLU-PP-332 | 1 | — | — | — | — | — |
| SNAP-8 | 1 | 98.68% | — | — |
| SS-31 | 1 | 99.04% | — | — | — |
| TB-500 (Thymosin B4) | 2 | 99.50% | — |
| Tesamorelin | 2 | 99.93% | — | — |
| Tesamorelin/Ipamorelin | 1 | 99.04% | — | — | — |
| Tesofensine | 1 | — | — | — | — | — |
| Testagen | 1 | 96.76% | — |
| Thymogen | 1 | 99.41% | — | — |
| Thymosin α1 | 1 | 99.67% | — | — |
| VIP | 1 | 99.27% | — | — | — |
| SER-010-MH-03 |
| Vanguard Laboratory |
| — |
| MSLALUSP<71>HM |
| — |
| View |
| Pinealon | PNL-010-MH-01 | ILS Labs | 99.00% | MSLALUSP<71>HM | 2026-06-19 | View |
| KPV | KPV-010-MH-05 | ILS Labs | 99.71% | LALUSP<71>HM | 2026-06-16 | View |
| AHK-Cu | AHK-100-MH-01 | ILS Labs | 99.98% | LALUSP<71>HM | 2026-06-16 | View |
| AOD-9604 | AOD-005-MH-02 | Kovera Labs | 99.96% | MSLALUSP<71>HM | 2026-03-24 | View |
| Tesamorelin | TES-010-MH-03 | Kovera Labs | 99.93% | MSLALUSP<71>HM | 2026-03-22 | View |
| Klow | KLW-080-MH-02 | Kovera Labs | 99.69% | MSLALUSP<71>HM | 2026-03-21 | View |
| Glow | GLW-070-MH-02 | Kovera Labs | 99.74% | MSLALUSP<71>HM | 2026-03-21 | View |
| PT-141 | PT1-010-MH-02 | Kovera Labs | 99.93% | MSLALUSP<71>HM | 2026-03-21 | View |
| TB-500 (Thymosin B4) | TB5-010-MH-04 | Kovera Labs | 99.92% | MSLALUSP<71>HM | 2026-03-20 | View |
| CJC-1295 (No DAC)/Ipamorelin | CIB-010-MH-01 | Kovera Labs | 99.87% | MSLALUSP<71>HM | 2026-03-20 | View |
| Cagrilintide | CAG-010-MH-02 | Kovera Labs | 99.95% | MSLALUSP<71>HM | 2026-03-20 | View |
| Melanotan-2 | MLN-010-MH-01 | Kovera Labs | 99.97% | MSLALUSP<71>HM | 2026-03-19 | View |
| MOTS-c | MOT-010-MH-03 | Kovera Labs | 99.74% | MSLALUSP<71>HM | 2026-03-18 | View |
| GLP-2 TRZ | GLP-260-MH-04 | Kovera Labs | 99.93% | MSLALUSP<71>HM | 2026-03-18 | View |
| Glutathion | GLU-150-MH-01 | Kovera Labs | 99.91% | MSLALUSP<71>HM | 2026-03-18 | View |
| 5-Amino-1MQ | AMN-050-MH-01 | Kovera Labs | 99.94% | MSLALUSP<71>HM | 2026-03-14 | View |
| Oxytocin | OXN-010-MH-01 | Kovera Labs | 99.93% | MSLALUSP<71>HM | 2026-03-14 | View |
| TB-500 | TB5-010-MH-03 | Vanguard Laboratory | 99.08% | LALUSP<71>HM | 2026-03-12 | View |
| SS-31 | SS3-010-MH-04 | Vanguard Laboratory | 99.04% | LALUSP<71>HM | 2026-03-12 | View |
| BPC-157 | BPC-500-MH-02 | Vanguard Laboratory | — | HM | 2026-03-11 | View |
| BPC-157/TB-500 | WLV-020-MH-02 | Kovera Labs | 99.94% | MSLALUSP<71>HM | 2026-03-10 | View |
| GHK-Cu | GHK-050-MH-03 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-09 | View |
| MHC-3RT | GLP-305-MH-01 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-09 | View |
| GHK-Cu | GHK-002-MH-01 | Vanguard Laboratory | — | HM | 2026-03-04 | View |
| Tesofensine | TSF-500-MH-02 | Vanguard Laboratory | — | HM | 2026-03-02 | View |
| BPC-157/KPV | KPC-001-MH-01 | Vanguard Laboratory | — | HM | 2026-03-01 | View |
| NAD+ | NAD-500-MH-04 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-01 | View |
| MHC-3RT | GLP-320-MH-01 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-01 | View |
| Tesamorelin | TES-010-MH-02 | Kovera Labs | 99.94% | MSLALUSP<71>HM | 2026-02-27 | View |
| Melanotan-1 | MT1-010-MH-01 | Kovera Labs | 99.98% | MSLALUSP<71>HM | 2026-02-26 | View |
| Tesamorelin/Ipamorelin | TIB-013-MH-01 | Vanguard Laboratory | 99.04% | LALUSP<71>HM | 2026-02-18 | View |
| IGF-1 LR3 | IGF-001-MH-02 | Vanguard Laboratory | 98.87% | — | 2026-02-13 | View |
| Semax | SMX-010-MH-04 | Vanguard Laboratory | 99.50% | LALUSP<71>HM | 2026-02-10 | View |
| Semax/Selank | SSB-020-MH-01 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-07 | View |
| MHC-3 RT | GLP-330-MH-04 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-07 | View |
| MOTS-c | MOT-010-MH-02 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-01-20 | View |
| KPV | KPV-010-MH-02 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-01-20 | View |
| VIP | VIP-010-MH-01 | Janoshik Analytical | 99.27% | LAL | 2026-01-02 | View |
| Prostamax | PMX-025-MH-01 | Chromate | 98.69% | LALHM | 2025-12-18 | View |
| Cardiogen | CRD-025-MH-01 | Chromate | 98.38% | LALHM | 2025-12-18 | View |
| BPC-157 | BPC-010-MH-03 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2025-12-18 | View |
| Thymogen | THY-025-MH-01 | Chromate | 99.41% | LALHM | 2025-12-18 | View |
| Testagen | TST-025-MH-01 | Chromate | 96.76% | MSLALHM | 2025-12-18 | View |
| Cartalax | CAR-025-MH-01 | Chromate | 99.91% | LALHM | 2025-12-18 | View |
| NAD+ | NAD-500-MH-03 | Chromate | 93.71% | LALHM | 2025-12-13 | View |
| ARA290 | ARA-012-MH-01 | Chromate | 99.60% | LALHM | 2025-12-12 | View |
| Wolverine 2.0 30mg | WL2-030-MH-01 | Chromate | 99.62% | LALUSP<71>HM | 2025-12-09 | View |
Disclosed Labs